Impaired bone formation in transgenic mice resulting from altered integrin function in osteoblasts

Area of Science:

• Bone biology
• Integrin signaling
• Skeletal development

Background:

• Integrins are essential cell surface receptors mediating cell-extracellular matrix interactions.
• Their specific role in mature osteoblasts in vivo remains incompletely understood.
• Osteoblast function is critical for maintaining bone mass and skeletal integrity.

Purpose of the Study:

• To investigate the in vivo function of integrins in mature osteoblasts.
• To elucidate the impact of impaired beta1 integrin signaling on bone formation and mass.
• To identify potential sex-specific differences in response to integrin dysfunction.

Main Methods:

• Generation of transgenic mice expressing a dominant-negative beta1 integrin subunit (beta1-DN) under the osteocalcin promoter.
• In vitro assessment of osteoblast differentiation and adhesion.
• In vivo analysis of bone mass, cortical porosity, and bone formation rates in transgenic and wild-type mice.
• Histological and histomorphometric evaluation of bone structure and cellular activity.

Main Results:

• Transgenic osteoblasts exhibited impaired adhesion upon activation of the osteocalcin promoter.
• Transgenic animals showed reduced bone mass, increased cortical porosity, and thinner skull bones.
• Bone formation rates were reduced, and osteoblasts displayed altered morphology and intracellular matrix accumulation.
• A sex-specific defect was observed, with reduced bone mass persisting in female transgenic mice at 90 days, accompanied by increased osteoclast activity.

Conclusions:

• Beta1 integrins play a critical role in maintaining adhesion and function of mature osteoblasts in vivo.
• Impaired integrin signaling leads to reduced bone formation and decreased bone mass.
• The study reveals a sex-specific vulnerability in bone maintenance in female mice with impaired osteoblast integrin function.